|
End-of-day quote
Buenos Aires S.E.
02/11/2026
|
5-day change | 1st Jan Change | ||
| 1,330.00 ARS | +1.92% |
|
+0.76% | -32.66% |
| Market Cap | 107B 69.56M 62.11M 56.99M 51.84M 97.2M 6.59B 99.14M 681M 274M 3.48B 261M 256M 10.98B | P/E 2024 |
6.08x | P/E 2025 | 51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 338B 219M 196M 180M 163M 306M 20.75B 312M 2.15B 865M 10.95B 823M 805M 34.6B | EV / Sales 2024 |
3.04x | EV / Sales 2025 | 3.08x |
| Free-Float |
17.54% | Yield 2024 |
1.5% | Yield 2025 | - |
Buenos Aires S.E.ARS
| Markets | Quality | ||
|---|---|---|---|
Buenos Aires S.E.
| RICH | End-of-day quote | |
Buenos Aires S.E.
| RICHD | End-of-day quote |
| 1 day | +1.92% | ||
| 1 week | +0.76% | ||
| Current month | +1.92% | ||
| 1 month | -11.92% | ||
| 3 months | -14.19% | ||
| 6 months | -18.65% | ||
| Current year | -32.66% |
| 1 week | 1,290 | 1,390 | |
| 1 month | 1,290 | 1,580 | |
| Current year | 1,290 | 2,130 | |
| 1 year | 1,290 | 2,300 | |
| 3 years | 595.5 | 2,300 | |
| 5 years | 215 | 2,300 | |
| 10 years | 24.8 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | - | - | |
| General Counsel | - | 29/04/2025 | |
| Corporate Officer/Principal | - | 29/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.92% | +0.76% | -16.61% | +93.31% | 69.56M | ||
| -0.46% | +10.31% | +63.52% | +143.15% | 1,257B | ||
| -0.97% | +1.60% | +43.25% | +80.09% | 651B | ||
| -2.05% | +0.73% | +32.47% | +101.62% | 510B | ||
| -0.19% | -0.60% | +52.83% | +67.17% | 388B | ||
| -0.78% | +5.51% | +72.55% | +44.25% | 366B | ||
| +0.74% | +2.81% | +33.07% | +58.87% | 303B | ||
| -0.09% | +8.17% | +12.18% | +35.05% | 288B | ||
| -0.12% | +4.68% | +55.97% | +74.59% | 252B | ||
| -0.21% | +7.34% | +42.19% | +109.69% | 211B | ||
| Average | +0.08% | +4.44% | +39.14% | +80.78% | 422.67B | |
| Weighted average by Cap. | -0.34% | +5.30% | +49.25% | +93.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 91.79B 59.46M 53.08M 48.71M 44.31M 83.08M 5.63B 84.73M 582M 235M 2.97B 223M 218M 9.38B | 127B 82.08M 73.28M 67.25M 61.17M 115M 7.77B 117M 803M 324M 4.1B 308M 301M 12.95B |
| Net income | 23.85B 15.44M 13.79M 12.65M 11.51M 21.58M 1.46B 22.01M 151M 60.92M 772M 57.97M 56.73M 2.44B | 3.09B 2M 1.79M 1.64M 1.49M 2.79M 189M 2.85M 19.57M 7.89M 99.94M 7.51M 7.35M 316M |
| Net Debt | 134B 86.56M 77.28M 70.92M 64.51M 121M 8.2B 123M 847M 341M 4.33B 325M 318M 13.66B | 231B 150M 134M 123M 112M 209M 14.17B 213M 1.46B 590M 7.48B 562M 550M 23.62B |
Employees
620
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/11/26 | ARS 1,330.00 | +1.92% | 827 |
| 30/10/26 | ARS 1,305.00 | +0.38% | 693 |
| 29/10/26 | ARS 1,300.00 | -5.80% | 982 |
| 28/10/26 | ARS 1,380.00 | +6.98% | 784 |
| 27/10/26 | ARS 1,290.00 | -2.27% | 993 |
- Stock Market
- Stocks
- RICH Stock
Select your edition
All financial news and data tailored to specific country editions

















